Stay updated on Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial

Sign up to get notified when there's something new on the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.1 to v3.4.2; no impact on study content or page usability.
    Difference
    0.0%
    Check dated 2026-02-13T12:42:42.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision metadata was updated: Revision: v3.4.1 was added and Revision: v3.4.0 was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T17:12:03.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Glossary toggle is now shown on the page. Minor textual updates include capitalization changes for 'Last Update Submitted' and 'No FEAR Act data', and a new revision label v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-29T07:35:03.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Sponsor field updated from FibroGen to Kyntra Bio. FibroGen is no longer listed as sponsor.
    Difference
    0.3%
    Check dated 2026-01-22T05:00:33.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4 added and Revision: v3.3.3 removed, indicating a minor internal version update. This change does not affect study details, eligibility criteria, or how a user interacts with the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T03:11:06.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    New Locations section added listing participating sites by state (Arizona, California, District of Columbia, Florida, Louisiana, Minnesota, Pennsylvania, Washington). The HHS Vulnerability Disclosure footer link was removed.
    Difference
    0.9%
    Check dated 2025-12-24T14:48:11.000Z thumbnail image

Stay in the know with updates to Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page.